Agilent Technologies Inc. of Santa Clara, Calif., and BioNanomatrix Inc. of Philadelphia have agreed to combine their technologies and collaborate on the development of a genetic analysis system. Their goal is to create and market an integrated system that enables nanoscale single-molecule identification and analysis of the entire genome rapidly and inexpensively.